Literature DB >> 11283810

Campylobacter jejuni Infections: update on emerging issues and trends.

B M Allos1.   

Abstract

Infection with Campylobacter jejuni is one of the most common causes of gastroenteritis worldwide; it occurs more frequently than do infections caused by Salmonella species, Shigella species, or Escherichia coli O157:H7. In developed countries, the incidence of Campylobacter jejuni infections peaks during infancy and again during early adulthood. Most infections are acquired by the consumption and handling of poultry. A typical case is characterized by diarrhea, fever, and abdominal cramps. Obtaining cultures of the organism from stool samples remains the best way to diagnose this infection. An alarming recent trend is the rapid emergence of antimicrobial agent--resistant Campylobacter strains all over the world. Use of antibiotics in animals used for food has accelerated this trend. It is fortunate that complications of C. jejuni infections are rare, and most patients do not require antibiotics. Guillain-Barré syndrome is now recognized as a post-infectious complication of C. jejuni infection, but its incidence is <1 per 1000 infections. Careful food preparation and cooking practices may prevent some Campylobacter infections.

Entities:  

Mesh:

Year:  2001        PMID: 11283810     DOI: 10.1086/319760

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  321 in total

1.  Comparison of molecular typing methods useful for detecting clusters of Campylobacter jejuni and C. coli isolates through routine surveillance.

Authors:  Clifford G Clark; Eduardo Taboada; Christopher C R Grant; Connie Blakeston; Frank Pollari; Barbara Marshall; Kris Rahn; Joanne Mackinnon; Danielle Daignault; Dylan Pillai; Lai-King Ng
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Antimicrobial resistance of Campylobacter isolates from retail meat in the United States between 2002 and 2007.

Authors:  S Zhao; S R Young; E Tong; J W Abbott; N Womack; S L Friedman; P F McDermott
Journal:  Appl Environ Microbiol       Date:  2010-10-22       Impact factor: 4.792

3.  Simultaneous presence of multiple Campylobacter species in dogs.

Authors:  M G J Koene; D J Houwers; J R Dijkstra; B Duim; J A Wagenaar
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Severe myelitis following infection with Campylobacter enteritis.

Authors:  J Aberle; J Kluwe; F Pawlas; H J Stellbrink; H Greten
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-15       Impact factor: 3.267

5.  Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp.

Authors:  Mirva Lehtopolku; Pirkko Kotilainen; Pauli Puukka; Ulla-Maija Nakari; Anja Siitonen; Erkki Eerola; Pentti Huovinen; Antti J Hakanen
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

6.  Different contributions of HtrA protease and chaperone activities to Campylobacter jejuni stress tolerance and physiology.

Authors:  Kristoffer T Baek; Christina S Vegge; Joanna Skórko-Glonek; Lone Brøndsted
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

Review 7.  Campylobacter jejuni transducer like proteins: Chemotaxis and beyond.

Authors:  Kshipra Chandrashekhar; Issmat I Kassem; Gireesh Rajashekara
Journal:  Gut Microbes       Date:  2017-01-12

8.  Bacterial N-Glycosylation Efficiency Is Dependent on the Structural Context of Target Sequons.

Authors:  Julie Michelle Silverman; Barbara Imperiali
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

Review 9.  Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.

Authors:  Markus M Heimesaat; Steffen Backert; Thomas Alter; Stefan Bereswill
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

Review 10.  The Data Behind Risk Analysis of Campylobacter Jejuni and Campylobacter Coli Infections.

Authors:  Racem Ben Romdhane; Roswitha Merle
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.